Apac Biotech is a biotechnology company in India developing a dendritic cell based personalised Immunotherapy, APCEDEN®, for cancer patients that has been proven to have immense potential in improving quality of life and provide survival benefit. Apac Biotech is the first company to receive the Indian FDA approval. We are currently looking for investors who can help us expand into the Indian market & increase our production capacity.